Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma

Summary

After the local treatment of the primary tumor (protonbeam-therapy, enucleation, external radiotherapy) patients with high risk of metastasis are randomized between: * Adjuvant chemotherapy with Fotemustin. * Observation Both groups are followed during 3 years for Metastasis- Free Survival, safety and tolerance of Fotemustin, quality of life, and Overall Survival.

Timeline

Start

2009-06-23

Primary completion

2020-06-12

Completion

2020-06-12

Drugs

Indications